This opportunity is no longer accepting applications.
grant PAR-22-062

Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)

This grant aims to support research exploring how the human microbiome affects the immune system's response to tumors, either by enhancing or inhibiting it. The goal is to find new molecular targets for preventing cancer. Applicants should focus on how interactions between specific microbes or their metabolites with the host impact immune responses relating to tumor formation. The research sho…

The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory/development basic research projects that elucidate mechanisms by which the human microbiome inhibit or enhance anti-tumor immune responses, and to identify potential novel molecular targets for cancer prevention…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Awards & funding

Award Ceiling: $275,000
Award Amount: $275,000

Dates

Opportunity Released: November 3, 2021
Open for Submission: November 3, 2021
Submission Deadline: January 7, 2025
Application Window Closes: January 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.